{"id":"https://openalex.org/W7225336149","doi":"https://doi.org/10.20944/preprints202611.0450.v1","title":"Prognostic Value of Imaging and Genomic Biomarkers in Systemic Therapy-Na\u00efve Metastatic Androgen Pathway Modulator-Na\u00efve Prostate Cancer Undergoing Radioligand Therapy","display_name":"Prognostic Value of Imaging and Genomic Biomarkers in Systemic Therapy-Na\u00efve Metastatic Androgen Pathway Modulator-Na\u00efve Prostate Cancer Undergoing Radioligand Therapy","publication_year":2026,"publication_date":"2026-11-05","ids":{"openalex":"https://openalex.org/W7225336149","doi":"https://doi.org/10.20944/preprints202611.0450.v1"},"language":"en","primary_location":{"id":"doi:10.20944/preprints202611.0450.v1","doi":"https://doi.org/10.20944/preprints202611.0450.v1","is_oa":true,"landing_page_url":"https://doi.org/10.20944/preprints202611.0450.v1","pdf_url":null,"source":{"id":"https://openalex.org/S6309402219","display_name":"Preprints.org","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.20944/preprints202611.0450.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5118277840","display_name":"Ilva Kristiana Langrate","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ilva K. Langrate","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046484849","display_name":"Heidemarie Ofner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heidemarie Ofner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060748481","display_name":"Holger Einspieler","orcid":"https://orcid.org/0009-0006-6617-0303","observed_orcids":["https://orcid.org/0009-0006-6617-0303"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Holger Einspieler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074807729","display_name":"Melanie R. Hassler","orcid":"https://orcid.org/0000-0002-9496-4411","observed_orcids":["https://orcid.org/0000-0002-9496-4411"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melanie R. Hassler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006385574","display_name":"Elisabeth Kretschmer\u2010Chott","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elisabeth Kretschmer-Chott","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085354204","display_name":"Adelina G\u00f6llner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adelina G\u00f6llner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049278262","display_name":"Oana Cristina Kulterer","orcid":"https://orcid.org/0000-0002-8919-2437","observed_orcids":["https://orcid.org/0000-0002-8919-2437"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oana C. Kulterer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044950118","display_name":"Stefan Schmitl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stefan Schmitl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160954587","display_name":"Lukas Nics","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lukas Nics","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160765061","display_name":"Pascal A. T. Baltzer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pascal A. T. Baltzer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113742219","display_name":"Shahrokh F. Shariat","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shahrokh F. Shariat","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048708393","display_name":"Marcus Hacker","orcid":"https://orcid.org/0000-0002-4222-4083","observed_orcids":["https://orcid.org/0000-0002-4222-4083"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marcus Hacker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160840119","display_name":"Gero Kramer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gero Kramer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5000308568","display_name":"Sazan Rasul","orcid":"https://orcid.org/0000-0003-2898-3232","observed_orcids":["https://orcid.org/0000-0003-2898-3232"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Sazan Rasul","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5000308568"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.6640999913215637,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.6640999913215637,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.24770000576972961,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.06310000270605087,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.871999979019165},{"id":"https://openalex.org/keywords/radioligand-therapy","display_name":"radioligand therapy","score":0.8889999985694885},{"id":"https://openalex.org/keywords/177lu-lu-psma","display_name":"[177Lu]Lu-PSMA","score":0.9549999833106995},{"id":"https://openalex.org/keywords/psma-pet-imaging","display_name":"PSMA PET imaging","score":0.7540000081062317},{"id":"https://openalex.org/keywords/imaging-biomarkers","display_name":"imaging biomarkers","score":0.7860000133514404},{"id":"https://openalex.org/keywords/standardized-uptake-value","display_name":"standardized uptake value","score":0.8769999742507935},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8650000095367432},{"id":"https://openalex.org/keywords/genetic-alterations","display_name":"genetic alterations","score":0.7089999914169312},{"id":"https://openalex.org/keywords/dna-repair-pathways","display_name":"DNA repair pathways","score":0.7609999775886536},{"id":"https://openalex.org/keywords/tp53","display_name":"TP53","score":0.8379999995231628},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.9259999990463257},{"id":"https://openalex.org/keywords/neurofibromatosis-type-1","display_name":"neurofibromatosis type 1","score":0.9470000267028809},{"id":"https://openalex.org/keywords/psa-progression-free-survival","display_name":"PSA progression-free survival","score":0.6990000009536743},{"id":"https://openalex.org/keywords/first-line-systemic-therapy","display_name":"first-line systemic therapy","score":0.7670000195503235},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.7839999794960022},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.4000000059604645}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8385000228881836},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.8133999705314636},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6402999758720398},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5881999731063843},{"id":"https://openalex.org/C67847695","wikidata":"https://www.wikidata.org/wiki/Q626478","display_name":"Radioligand","level":3,"score":0.5727999806404114},{"id":"https://openalex.org/C134305767","wikidata":"https://www.wikidata.org/wiki/Q725508","display_name":"Somatic cell","level":3,"score":0.5163000226020813},{"id":"https://openalex.org/C2777911890","wikidata":"https://www.wikidata.org/wiki/Q62614","display_name":"Androgen","level":3,"score":0.4925999939441681},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.47279998660087585},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.43230000138282776},{"id":"https://openalex.org/C2781406297","wikidata":"https://www.wikidata.org/wiki/Q409450","display_name":"Prostate-specific antigen","level":4,"score":0.42250001430511475},{"id":"https://openalex.org/C2778311097","wikidata":"https://www.wikidata.org/wiki/Q5903784","display_name":"Hormonal therapy","level":4,"score":0.3982999920845032},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.397599995136261},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.37709999084472656},{"id":"https://openalex.org/C109825262","wikidata":"https://www.wikidata.org/wiki/Q1139164","display_name":"Germline","level":3,"score":0.37470000982284546},{"id":"https://openalex.org/C199374082","wikidata":"https://www.wikidata.org/wiki/Q907080","display_name":"Standardized uptake value","level":3,"score":0.34529998898506165},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.3418000042438507},{"id":"https://openalex.org/C13514818","wikidata":"https://www.wikidata.org/wiki/Q5552256","display_name":"Germline mutation","level":4,"score":0.33820000290870667},{"id":"https://openalex.org/C20417620","wikidata":"https://www.wikidata.org/wiki/Q4140229","display_name":"Glutamate carboxypeptidase II","level":4,"score":0.3255999982357025},{"id":"https://openalex.org/C2777008409","wikidata":"https://www.wikidata.org/wiki/Q4914714","display_name":"Biochemical recurrence","level":5,"score":0.3172999918460846},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.301800012588501},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.29840001463890076},{"id":"https://openalex.org/C87874733","wikidata":"https://www.wikidata.org/wiki/Q18039844","display_name":"PCA3","level":4,"score":0.29789999127388},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.29019999504089355},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.2833000123500824},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.272599995136261},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.25450000166893005},{"id":"https://openalex.org/C61238886","wikidata":"https://www.wikidata.org/wiki/Q5121689","display_name":"Circulating tumor cell","level":4,"score":0.25279998779296875}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.20944/preprints202611.0450.v1","doi":"https://doi.org/10.20944/preprints202611.0450.v1","is_oa":true,"landing_page_url":"https://doi.org/10.20944/preprints202611.0450.v1","pdf_url":null,"source":{"id":"https://openalex.org/S6309402219","display_name":"Preprints.org","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.20944/preprints202611.0450.v1","doi":"https://doi.org/10.20944/preprints202611.0450.v1","is_oa":true,"landing_page_url":"https://doi.org/10.20944/preprints202611.0450.v1","pdf_url":null,"source":{"id":"https://openalex.org/S6309402219","display_name":"Preprints.org","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7128733427","https://openalex.org/W2977265552","https://openalex.org/W4403771333","https://openalex.org/W2887253217","https://openalex.org/W4410809341","https://openalex.org/W4324137015","https://openalex.org/W4362541119","https://openalex.org/W3133507743","https://openalex.org/W4395469417","https://openalex.org/W4413363109"],"abstract_inverted_index":{"BACKGROUND:":[0],"[177Lu]Lu-prostate-specific":[1],"membrane":[2],"antigen":[3,111],"(PSMA)-targeted":[4],"radioligand":[5],"therapy":[6,118],"(RLT)":[7],"has":[8],"demonstrated":[9],"clinical":[10,49],"efficacy":[11],"in":[12,43,51,142,252,287],"metastatic":[13,19],"androgen":[14,116],"pathway":[15,216],"modulator-na\u00efve":[16],"(mAPMN)":[17],"and":[18,40,48,87,97,115,125,144,163,226,254],"castration-resistant":[20],"prostate":[21],"cancer":[22],"(mCRPC),":[23],"however":[24],"treatment":[25,275],"responses":[26],"remain":[27],"heterogeneous.":[28],"PURPOSE:":[29],"To":[30],"evaluate":[31],"the":[32],"prognostic":[33,280],"value":[34,81],"of":[35,250],"PSMA":[36,88,270],"PET-derived":[37,271],"imaging":[38,103],"biomarkers":[39],"genomic":[41,127,283],"alterations":[42,128,284],"relation":[44],"to":[45],"biochemical":[46],"response":[47,104,276],"outcomes":[50],"systemic":[52,63,243],"therapy-na\u00efve":[53,67,244],"patients":[54,68,137,245],"with":[55,69,74,102,133,148,185,210,235,246,260,263,267,282],"mAPMN":[56,70,247],"PCa":[57,71],"receiving":[58],"[177Lu]Lu-PSMA":[59],"RLT":[60],"as":[61,106],"first-line":[62],"therapy.":[64],"METHODS:":[65],"Systemic":[66],"treated":[72],"exclusively":[73],"[177Lu]Lu-PSMA-RLT":[75],"were":[76,93,121,129,138,146,239,258],"retrospectively":[77],"analyzed.":[78,139],"Standardized":[79],"uptake":[80],"(SUV)":[82],"parameters":[83,272],"(SUVmax,":[84],"SUVmean,":[85],"SUVpeak)":[86],"total":[89],"tumor":[90],"volume":[91],"(PSMA-TTV)":[92],"derived":[94],"from":[95],"baseline":[96,219],"post-treatment":[98],"[68Ga]Ga-PSMA-11":[99],"PET":[100],"scans,":[101],"defined":[105],"a":[107],"\u226530%":[108,141,181,251],"reduction.":[109],"Prostate-specific":[110],"(PSA)":[112],"response,":[113],"PSA-PFS":[114,150,187],"deprivation":[117],"(ADT)-free":[119],"survival":[120,165],"assessed.":[122],"Available":[123],"germline":[124],"somatic":[126,201],"analyzed":[130],"for":[131],"associations":[132,234],"outcomes.":[134],"RESULTS:":[135],"26":[136],"Reductions":[140],"SUVmax":[143,253],"PSMA-TTV":[145,255],"associated":[147,184,259,266],"prolonged":[149,186,268],"(27.1":[151],"vs.":[152,157,167,172,222,229],"9.4":[153],"months,":[154,159,169,174],"p=0.01;":[155],"27.1":[156],"5.5":[158],"p<":[160],"0.001,":[161],"respectively)":[162],"ADT-free":[164],"(39.0":[166],"19.9":[168],"p=0.03;":[170],"23.9":[171],"13.8":[173],"p=0.028,":[175],"respectively).":[176],"In":[177,242],"multivariable":[178],"analysis,":[179],"\u0394PSMA-TTV":[180,264],"was":[182,285],"independently":[183,265],"(HR":[188],"0.23,":[189],"95%":[190],"CI":[191],"0.08-0.68;":[192],"p=0.008).":[193],"Of":[194],"17":[195],"genomically":[196],"profiled":[197],"patients,":[198],"nine":[199],"had":[200,217],"alterations,":[202],"most":[203],"frequently":[204],"involving":[205],"TP53,":[206],"MYC,":[207],"NF1.":[208],"Patients":[209],"altered":[211],"DNA":[212],"damage":[213],"repair":[214],"(DDR)":[215],"lower":[218],"PSA":[220],"(0.78":[221],"12.3":[223],"ng/mL;":[224],"p=0.03)":[225],"SUVpeak":[227],"(7.9":[228],"16.7;":[230],"p=0.03).":[231],"No":[232],"other":[233],"genetic":[236],"alteration":[237],"status":[238],"observed.":[240],"CONCLUSIONS:":[241],"PCa,":[248],"reductions":[249],"following":[256],"PSMA-RLT":[257],"favorable":[261],"outcomes,":[262],"PSA-PFS.":[269],"may":[273],"support":[274],"assessment,":[277],"whereas":[278],"no":[279],"association":[281],"identified":[286],"this":[288],"cohort.":[289]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-06T00:00:00"}